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December 20091324 Vogel et alwell, only two interventional radiologists were identified
using this methodology and were excluded from the anal-
ysis. Finally, there is a bias in this study as all the procedures
were performed in hospitals and no outpatient facilities are
contained within the data set.
In conclusion, physician specialty was not found to
significantly influence patient outcomes or complications
for LE PTA. We have demonstrated that hospital resource
utilization varied significantly by specialty with vascular
surgeons demonstrating the lowest utilization of hospital
resources for LE PTA compared to cardiologists. We found
that high volume practitioners also used significantly fewer
medical supplies and had lower hospital resource utilization
for performing LE PTA. Furthermore, cardiologists were
more likely treat claudicants with greater use of hospital
resources. Explanations for these variations remains un-
clear, but further analysis to explain these disparities may
offer substantial cost savings for lower extremity angio-
plasty in the future.
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Dr G. Patrick Clagett (Dallas, Tex). Where do the interven-
tional radiologists stand?
Dr Vogel.We analyzed the volume of interventional radiolo-
gists utilizing the same methodology in this presentation and a
previously published study. In the state of New Jersey, the inter-
ventional radiologists have had a significant reduction in case
volume in the years analyzed. The volume was insufficient to
perform a comparative analysis.
DrMaciej Dryjski (Buffalo, NY). I have one question. Could
you tell us a little bit more about this database? Was it only
hospitalized patients or also outpatients? If in fact only inpatients
were included, you missed a great number of endovascular cases.
Dr Vogel.We utilized the publicly available New Jersey State
Inpatient Database (SID), which was developed as part of the
Healthcare Cost and Utilization Project (HCUP) sponsored by
the Agency for Health Care Research and Quality (AHRQ). The
NJ SID includes inpatient discharge abstracts from all acute care
hospitals in the state and contains more than 200 data elements.
The data are based on ICD-9 codes, which are primarily billingIndications for the procedure of angioplasty included claudication,
rest pain, and gangrene.
The data set contains only inpatient admissions and does not
include surgicenters. Therefore, this study may be biased for a
sicker cohort, as they were all performed in the hospital setting.
DrDryjski.Themajority of angioplasties are performed on an
outpatient basis, particularly by cardiologists.
Dr Vogel. If procedures are performed in a hospital setting,
they are likely contained within the data set, although this data set
does not contain outpatient surgicenters.
Dr Gary Giangola (Staten Island, NY). I’m not here to
defend the cardiologists, but if one were to do a prospective study,
one would find that vascular surgeons probably are doing interven-
tion on a higher percentage of claudicants than you obtained in this
retrospective New Jersey state database. Cardiologists are more
inclined to list the indication as claudication. Vascular surgeons
should know better than to treat claudication and aremore likely to
exaggerate and list the indication as rest pain or ischemic ulcer for
minimal skin problems in the foot. I would predict that in a
prospective study, one would find that vascular surgeons are treat-
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study indicates, a practice that we need to question.
Dr Vogel. I agree. Neither specialty can be defined as “saints.”
The reality is that we can debate whether or not claudication should
even be treated with an intervention. Both specialties will need to
address the issue of interventions on claudicants in the future and, in
my opinion, create defined guidelines for intervention.
Dr Giangola. You re-emphasize a good point. The issue is:
How should we treat claudication?
Dr Vogel. An excellent example is carotid stenting. Carotid
stenting has been tempered by strict criteria linked to reimburse-
ment. Perhaps guidelines linked to reimbursement are required for
lower extremity angioplasty in the management of claudicants.
Dr Ralph Pfeiffer (Mobile, Ala). I appreciate your data. Your
data reflect our own experience in Mobile.
Dr Peter Paik (Irvine, Calif). My question is, when these
cardiologists were doing these procedures, were they doing them
as an additional procedure? Were they doing angiograms for
cardiology purposes?
Dr Vogel. This information cannot be discerned from the
data. However, I can tell you that angioplasty that was non-Dr Paik. From my local experience, a lot of cardiologists are
actually performing these procedures, since they’re doing angio-
gram and they know the patient has claudication, they usually go
down and intervene in those, so that may be a factor.
Dr Vogel. Perhaps.
Dr Hasan Dosluoglu (Buffalo, NY). I’d like to make a
comment about your comment that we’re not saints. In the VA
population, it’s about 65% to 70% critical limb ischemia, and 30%
claudicants. So it is unfortunate that the VA with its different
reimbursement system is not included in this analysis. I’d like to
hear your comment on that.
And second, what constituted the difference in cost between
the cardiologists and the vascular surgeons? Were the cardiologists
using more stents or other toys for re-entry, or laser?
Dr Vogel. Unfortunately I cannot comment on the VA
system as it is not contained within the state data set sponsored by
AHRQ. Regarding cost based on specialist, one would need to
perform a root cause hospital-based analysis. My hypothesis is that
different specialties utilize more catheters, wires, reentry devices,
and ultrasound. All of these entities add to the total procedural costcoronary was the principal procedure for the cohort we evaluated. captured in the data I have presented.
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